Dr Reddys out of key antiviral drug Remdesivir stock Medical Dialogues Team19 April 2021 3:06 PM ISTHyderabad: Hyderabad based drugmaker Dr Reddy's Laboratories recently announced that the manufacturer has been running out of stock of the key...
Prices of Remdesivir slashed, now as cheap as Rs 899, says NPPA Farhat Nasim18 April 2021 11:03 AM ISTNew Delhi: Through a recent office memorandum, National Pharmaceutical Pricing Authority (NPPA) has announced a reduction in the price of seven brands...
Dr Reddys Baddi unit gets Drug Controller nod to produce Remdesivir for domestic use Medical Dialogues Team14 April 2021 4:36 PM ISTBaddi: Drug major Dr Reddy's Laboratories' has recently secured permission from the Drug Controller to develop the antiviral Remdesivir, which is a...
Indian regulator nod for Sputnik V expected in next few weeks: Dr Reddys Ruchika Sharma30 March 2021 1:28 PM ISTObserving that trials of the vaccine have been conducted in Russia, India, the UAE and others, Sapra said the vaccine demonstrated an efficacy of 91.6...
Sputnik V could be third COVID-19 vaccine for India: Experts MD Bureau7 March 2021 9:15 AM ISTNew Delhi: To cater to the vaccination process of the world's largest democracy, it would be pertinent to bring in safer and more effective...
Submit more immunogenicity, safety data on Sputnik V vaccine: CDSCO panel to Dr Reddys Ruchika Sharma25 Feb 2021 12:38 PM ISTOnce Dr Reddy's Labs submits the data, its Emergency Use Authorization application will be considered," a source said.
Dr Reddy's Labs launches generic Prolixin tablets in US Ruchika Sharma19 Feb 2021 12:08 PM ISTHyderabad and Princeton: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced the launch of Fluphenazine Hydrochloride Tablets,...
Dr Reddys launches generic equivalent of Xeloda in US Hina Zahid17 Feb 2021 10:00 AM ISTThe product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA), Dr...
Dr Reddys, GRA terminate Avigan Trial Study for COVID-19 in Kuwait Ruchika Sharma28 Jan 2021 12:00 PM ISTHyderabad: Dr. Reddy's Laboratories Ltd. and Global Response Aid FZCO (GRA) have recently announced the termination of Avigan Trial Study conducted...
Russian COVID vaccine: Sputnik V meets primary safety endpoint in Phase 2 Clinical Trial in India Ruchika Sharma12 Jan 2021 12:32 PM ISTThe safety data has been submitted to the Drugs Controller General of India (DCGI) for review and approval to continue phase 3 clinical trials.
Dr. Reddy's Labs unveils generic Uloric Tablets in US Ruchika Sharma12 Jan 2021 11:00 AM ISTHyderabad & Princeton: Dr. Reddy's Laboratories Ltd. has recently announced the launch of Febuxostat Tablets.The product is a therapeutic...
Dr Reddys, Global Response Aid, Appili Therapeutics file for COVID drug REEQONUS Ruchika Sharma23 Dec 2020 1:36 PM ISTREEQONUS is also known as Avigan (favipiravir) Tablets developed by FUJIFILM Toyama Chemical Co., Ltd.
